Message #7 From:
NewsBot Date: September 19, 2005 01:00:00 AM
ITPD News RxFS Begins Fulfillment Operations with McKesson Corporation as its Primary Supplier of Pharmaceuticals
HOUSTON--(BUSINESS WIRE)--Sept. 19, 2005--Rx Fulfillment Services, Inc., a wholly owned subsidiary of Intrepid Holdings, Inc. (OTCBB:ITPD), announced today it began pharmacy fulfillment operations this month and has selected McKesson Corporation (NYSE:MCK) as its primary supply partner for all of its pharmacy operations.
"McKesson is providing prescription and over-the-counter drugs to RxFS' pharmacy operations," states Toney means, CEO of RxFS. "McKesson offers a supply efficiency that provides us the ability to consistently meet the drug and price point requirements of our customers throughout the country and we are looking forward to working with McKesson as we continue to expand our business," added Means.
McKesson Corporation is the leading provider of supply, information and care management products and services designed to reduce costs and improve quality across healthcare. McKesson solutions empower healthcare professionals with the tools they need to deliver care more effectively and efficiently. Founded in 1833, with annual revenues of more than $50 billion, McKesson ranks as the 16th largest industrial company in the United States.
This press release contains various forward-looking statements and information, including management's expectations of revenues, earnings per share, operating margins and growth in certain markets that are based on management's belief as well as assumptions made by and information currently available to management. Although the company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Such statements are subject to certain risks, uncertainties and assumptions including, among other matters, changes in market conditions, availability of funding and competition for venture capital investments. Should one or more of these risks materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those expected. For a discussion of the risks, investors are urged to refer to the company's reports filed under the Securities Exchange Act of 1934.
